Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 1
1947 1
1949 1
1950 2
1951 2
1952 5
1953 4
1954 4
1955 3
1956 2
1957 1
1958 5
1959 5
1960 8
1961 5
1962 4
1963 3
1964 8
1965 10
1966 5
1967 8
1968 11
1969 14
1970 21
1971 17
1972 16
1973 22
1974 16
1975 20
1976 26
1977 31
1978 56
1979 34
1980 42
1981 29
1982 39
1983 43
1984 47
1985 47
1986 44
1987 46
1988 66
1989 78
1990 78
1991 73
1992 72
1993 83
1994 59
1995 53
1996 73
1997 49
1998 79
1999 76
2000 68
2001 63
2002 70
2003 62
2004 67
2005 71
2006 78
2007 93
2008 95
2009 94
2010 131
2011 124
2012 135
2013 134
2014 145
2015 160
2016 152
2017 177
2018 136
2019 144
2020 162
2021 195
2022 177
2023 59
Text availability
Article attribute
Article type
Publication date

Search Results

3,974 results
Results by year
Filters applied: . Clear all
Page 1
Engineering precision nanoparticles for drug delivery.
Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Mitchell MJ, et al. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. Nat Rev Drug Discov. 2021. PMID: 33277608 Free PMC article. Review.
Nanomaterials for T-cell cancer immunotherapy.
Gong N, Sheppard NC, Billingsley MM, June CH, Mitchell MJ. Gong N, et al. Among authors: mitchell mj. Nat Nanotechnol. 2021 Jan;16(1):25-36. doi: 10.1038/s41565-020-00822-y. Epub 2021 Jan 12. Nat Nanotechnol. 2021. PMID: 33437036 Review.
Proton-driven transformable nanovaccine for cancer immunotherapy.
Gong N, Zhang Y, Teng X, Wang Y, Huo S, Qing G, Ni Q, Li X, Wang J, Ye X, Zhang T, Chen S, Wang Y, Yu J, Wang PC, Gan Y, Zhang J, Mitchell MJ, Li J, Liang XJ. Gong N, et al. Among authors: mitchell mj. Nat Nanotechnol. 2020 Dec;15(12):1053-1064. doi: 10.1038/s41565-020-00782-3. Epub 2020 Oct 26. Nat Nanotechnol. 2020. PMID: 33106640 Free PMC article.
Ionizable lipid nanoparticles for in utero mRNA delivery.
Riley RS, Kashyap MV, Billingsley MM, White B, Alameh MG, Bose SK, Zoltick PW, Li H, Zhang R, Cheng AY, Weissman D, Peranteau WH, Mitchell MJ. Riley RS, et al. Among authors: mitchell mj. Sci Adv. 2021 Jan 13;7(3):eaba1028. doi: 10.1126/sciadv.aba1028. Print 2021 Jan. Sci Adv. 2021. PMID: 33523869 Free PMC article.
Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery.
Zhang H, Han X, Alameh MG, Shepherd SJ, Padilla MS, Xue L, Butowska K, Weissman D, Mitchell MJ. Zhang H, et al. Among authors: mitchell mj. J Biomed Mater Res A. 2022 May;110(5):1101-1108. doi: 10.1002/jbm.a.37356. Epub 2022 Jan 25. J Biomed Mater Res A. 2022. PMID: 35076171
Reply.
Szabo G, Mitchell M, McClain CJ, Dasarathy S, Barton B, McCullough AJ, Nagy LE, Kroll-Desrosiers A, Tornai D, Min HA, Radaeva S, Casey L, Cuthbert J. Szabo G, et al. Among authors: mitchell m. Hepatology. 2022 Nov;76(5):E114-E115. doi: 10.1002/hep.32645. Epub 2022 Jul 16. Hepatology. 2022. PMID: 35778779 No abstract available.
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE).
Parhiz H, Brenner JS, Patel PN, Papp TE, Shahnawaz H, Li Q, Shi R, Zamora ME, Yadegari A, Marcos-Contreras OA, Natesan A, Pardi N, Shuvaev VV, Kiseleva R, Myerson JW, Uhler T, Riley RS, Han X, Mitchell MJ, Lam K, Heyes J, Weissman D, Muzykantov VR. Parhiz H, et al. Among authors: mitchell mj. J Control Release. 2022 Apr;344:50-61. doi: 10.1016/j.jconrel.2021.12.027. Epub 2021 Dec 23. J Control Release. 2022. PMID: 34953981 Free PMC article.
3,974 results